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Abstract
Background: Plasmids containing hylEfm (pHylEfm) were previously shown to increase gastrointestinal colonization
and lethality of Enterococcus faecium in experimental peritonitis. The hylEfm gene, predicting a glycosyl hydrolase,
has been considered as a virulence determinant of hospital-associated E. faecium, although its direct contribution
to virulence has not been investigated. Here, we constructed mutants of the hylEfm-region and we evaluated their
effect on virulence using a murine peritonitis model.
Results: Five mutants of the hylEfm-region of pHylEfmTX16 from the sequenced endocarditis strain (TX16 [DO]) were
obtained using an adaptation of the PheS* system and were evaluated in a commensal strain TX1330RF to which
pHylEfmTX16 was transferred by mating; these include i) deletion of hylEfm only; ii) deletion of the gene downstream
of hylEfm (down) of unknown function; iii) deletion of hylEfm plus down; iv) deletion of hylEfm-down and two adjacent
genes; and v) a 7,534 bp deletion including these four genes plus partial deletion of two others, with replacement
by cat. The 7,534 bp deletion did not affect virulence of TX16 in peritonitis but, when pHylEfmTX16Δ7,534 was
transferred to the TX1330RF background, the transconjugant was affected in in vitro growth versus TX1330RF
(pHylEfmTX16) and was attenuated in virulence; however, neither hylEfm nor hylEfm-down restored wild type function.
We did not observe any in vivo effect on virulence of the other deletions of the hylEfm-region
Conclusions: The four genes of the hylEfm region (including hylEfm) do not mediate the increased virulence
conferred by pHylEfmTX16 in murine peritonitis. The use of the markerless counterselection system PheS* should
facilitate the genetic manipulation of E. faecium in the future.
Background
Enterococcus faecium is a common enterococcal species
increasingly isolated from hospital-associated infections
in the USA [1]. Compelling evidence suggests that this
substantial increase in E. faecium nosocomial infections
is due to the worldwide occurrence of a genetic subclus-
ter (designated clonal cluster 17, CC17) which encom-
passes clones that appear to have evolved independently
[2-4]. Several genes have been associated with CC17 E.
faecium including i) espEfm, encoding a surface protein
which has been associated with increased biofilm forma-
tion and urinary tract infection (UTI) [4-6]; ii) some fms
genes (two of which are also designated pilA and pilB),
encoding putative microbial surface components recog-
nizing adhesive matrix molecules (MSCRAMMs) or
components of enterococcal pili (including the pilus
operon ebpABCfm, which appear to play a role in biofilm
formation and experimental UTI) [2,7-10]; iii) an intact
acm gene encoding a collagen adhesin which was shown
to be important in the pathogenesis of endocarditis [8]
and, iv) plasmids carrying the hylEfm gene [11-14].
It has been previously shown that hylEfm is carried by
large transferable megaplasmids of different sizes (145
to 375 kb) in hospital-associated E. faecium which are
widely distributed worldwide [11-13,15] These plasmids
also can harbour antibiotic resistance determinants and
some pilus-encoding genes of E. faecium which are pre-
sent with hylEfm in the same plasmid [15,16]. The
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laboratory strain (D344SRF) from a US clinical isolate
(C68) increased the colonization of the gastrointestinal
tract of mice, an effect that was independent of the pre-
sence of antibiotic resistance determinants [17]. More-
over, the acquisition of the hylEfm-plasmid from another
US clinical strain (TX16) increased the virulence of a
commensal strain E. faecium TX1330RF in experimental
peritonitis [11].
The HylEfm protein was initially predicted to have
homology with hyaluronidases which have been asso-
ciated with virulence in other gram-positive pathogens
[18,19], although hyaluronidase activity has not been
detected in E. faecium isolates carrying this gene [15].
The most recent annotation and sequence comparisons
indicate that this protein is likely to encode a family 84
glycosyl hydrolase [12,13]. In fact, the homolog of hylEfm
in Streptococcus pyogenes (spy1600) encoded in a genetic
locus with a similar organization to that of the hylEfm-
region and sharing 42% identity at the amino acid level
(61% similarity), was recently shown not to have any
detectable hyaluronidase activity. Spy1600 was charac-
terized as a family 84 glycosyl hydrolase with b-N-
acetyl-glucosaminidase specificity after purification and
substrate analysis [20] and expression of spy1600 in S.
pyogenes was found to be up-regulated during phagocy-
tosis [21]. For this reason, and because of the almost
exclusive occurrence of hylEfm in isolates from clinical
origin in different surveillance studies [14,22-24], this
gene has been postulated as an important pathogenic
determinant of hospital-associated E. faecium.H o w e v e r ,
its exact role in virulence has not been established. In
this work, we assess the role of the hylEfm-region in E.
faecium pathogenesis of experimental peritonitis.
Methods
Bacterial strains and plasmids
Table 1 and Figure 1 show the strains and plasmids
used in this work and depict the genetic organization of
the hylEfm-region in E. faecium strains and mutants.
Table 1 E. faecium strains and plasmids used in this work
Strains/Plasmids Relevant Characteristics Reference
Strains
E. faecium
TX16 (DO) Sequenced endocarditis clinical isolate, Em
r,S m
r. ST-16
a http://www.hgsc.bcm.tmc.edu [35]
TX1330RF Fs
r and Rf
r derivative of TX1330, a faecal colonizing strain from a healthy human volunteer [11]
TX1330RF (pHylEfmTX16) Derivative of TX1330RF to which the hylEfm-containing plasmid (pHylEfmTX16) was transferred by conjugation
from TX16 (DO) (~250 kb)
[11]
TX1330RF
(pHylEfmTX16Δ7,534)
Mutant with deletion of part or all of 6 genes of the hylEfm region of TX1330RF(pHylEfmTX16) This work
TX1330RF
(pHylEfmTX16Δ4genes)
Non-polar deletion of 4 genes of the hylEfm region of TX1330RF(pHylEfmTX16) This work
TX1330RF
(pHylEfmTX16Δhyl)
Non-polar deletion mutant of hylEfm of TX1330RF(pHylEfmTX16) This work
TX1330RF
(pHylEfmTX16Δhyl-down)
Non-polar deletion of hylEfm plus its downstream gene of TX1330RF(pHylEfmTX16) This work
TX1330RF
(pHylEfmTX16Δdown)
Non-polar deletion of the gene downstream of hylEfm of TX1330RF(pHylEfmTX16) This work
E. faecalis
CK111 OG1Sp upp4::P23 repA4 [25]
Plasmids
pHylEfmTX16 Conjugative and transferable megaplasmid (ca. 250 kb) of TX16 (DO) containing hylEfm [11]
pCJK47 Conjugative donor plasmid for markerless mutagenesis; oriTpCF10 and pheS* pORI280 derivative; confers Em
r [25]
pHOU1 Derivative of pCJK47 in which the erm(C) gene was replaced by aph-2’-ID; confers Gm
r This work
pHOU2 Derivative of pCJK47 in which the erm(C) gene was replaced by aph-2’-ID and cat was incorporated in the
cloning site for allelic replacements; confers Gm
r.
This work
pTEX5501ts E. coli-enterococcal shuttle plasmid for mutagenesis using a temperature-sensitive replicon [27]
pAT392 oriRpAMb1, oriRpUC oriTRK2 spc lacZa P2 aac(6’)-aph(2”) [30]
pAT392::hylEfm Derivative of pAT392 containing hylEfm (cloned with SacI and SmaI) under the control of the P2 promoter This work
pAT392::hylEfm-down Derivative of pAT392 containing both the hylEfm plus downstream genes (cloned with SacI and SmaI) under
the control of the P2 promoter
This work
Em
r, erythromycin resistance; Fs
r, fusidic acid resistance; Gm
r, gentamicin resistance, Rf
r, rifampin resistance; Sm
r, high-level resistance to streptomycin.
aST refers
to sequence type after multi-locus sequence typing. ST16 is part of CC17.
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using the pheS* counter-selection system in TX16
(pHylEfmTX16) and its transfer to TX1330RF
The pheS* system (previously used in Enterococcus fae-
calis) [25] is based on the acquired sensitivity of bacteria
to p-chloro-phenylalanine (p-Cl-Phe) if they carry a
pheS* allele encoding a phenylalanine tRNA synthetase
with altered substrate specificity [25,26]. In order to
apply this approach to E. faecium strains, which are
commonly macrolide resistant, we constructed a deriva-
tive of the pheS* vector pCJK47 by replacing its erm(C)
gene with aph2"-ID, which confers resistance to genta-
micin. The full aph-2"-ID gene (including promoter and
terminator regions) was amplified by PCR using plasmid
pTEX5501ts [27] as the template with primers A and B
(Table 2). The amplified fragment (1,089 bp) was
digested with NsiI and BglII and ligated with pCJK47
digested with the same enzymes resulting in pHOU1
(Figure 2A). Subsequently, pHOU1 was digested with
BamHI and PstI and ligated with a 992 bp fragment
released from pTEX5501ts after digestion with the same
enzymes and containing the chloramphenicol acetyl-
transferase gene (cat), obtaining a 7,906 bp vector desig-
nated pHOU2 (Figure 2B).
In order to create a deletion mutant of the hylEfm-
region (which contains genes predicted to be involved in
carbohydrate metabolism and transport; Figure 1), frag-
ments upstream (977 bp) and downstream (999 bp) of
this region were amplified by PCR (with primers C-D
and E-F, respectively; Table 2) and cloned upstream and
downstream of the cat gene in pHOU2, respectively,
using BamHI and XhoI for the upstream fragment and
ApaI and EcoRI for the downstream fragment; the cor-
rect insert was confirmed by sequencing in both
Figure 1 Physical map of the hylEfm-region in pHylEfmTX16. The annotated predicted function of the corresponding genes is shown above
the genes. The genes were divided into three groups (metabolism, transport [in gray] and regulation based on putative functions). Strain
nomenclature follows that specified in Table 1. Black arrows above the genes indicate the position of the primers used to obtain DNA fragments
for mutagenesis and follow the nomenclature of Table 2. The crosses depict the genes that were deleted. The asterisks indicate only partial
deletion of the gene was obtained.
aThe number refers to the glycosyl hydrolase family with hylEfm depicted in bold;
ballelic replacement with
the chloramphenicol acetyl transferase gene (cat) was performed. NA, not applicable.
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into E. faecalis CK111 by electroporation as described
previously [25,28] and blue colonies were recovered on
brain heart infusion (BHI) agar plates containing genta-
micin (125 μg/ml) and X-Gal (200 μg/ml). Subsequently,
the pHOU2 derivatives were introduced into strain
TX16 by filter mating [29] with E. faecalis CK111 as the
donor. Single cross-over integrants were selected on
gentamicin (170 μg/ml) and erythromycin (200 mg/ml)
and purified colonies were then resuspended in 50 μlo f
normal saline and plated on MM9YEG media (salts and
yeast extract) supplemented with 7 mM of p-Cl-Phe
[25] and incubated for 48 h at 37°C. To confirm that
colonies which grew on MM9YEG media supplemented
Table 2 Primers used in this work
Primer Sequence (5’-3’) Relevant Characteristics
Ag a agatctgagataggttatgcaagat Forward, BglII site (underlined), used amplification of aph-2"-ID
B ccaatgcatgattccggattctaaaaaagg Reverse, NsiI site (underlined), used amplification of aph-2"-ID
C cgggatccgtttaaaaccagctggaaaag Forward, BamHI site (underlined), located 1,251 nucleotides upstream of the start codon of
the gene encoding a putative glycosyl hydrolase family 20 (Figure 1.)
D ccgctcgagcaattcaacattgcaaagac Reverse, XhoI site (underlined), located 294 nucleotides upstream of the start codon of the
gene encoding a putative glycosyl hydrolase family 20 (Figure 1.)
E cgagggcccgtgaagtattgccagatgt Forward, ApaI site (underlined); located 592 nucleotides downstream of the down gene
(hypothetical, Figure 1.)
F ccggaattcaaaagcagaattggaaatca Reverse, EcoRI site, 1,571 nucleotides downstream of the down gene (hypothetical, Figure 1.)
Gg c gagctcgattactttcaaaggaga Forward, SacI site (underlined), ribosomal binding site of hylEfm (italics) (Figure 1.)
H tcccccgggctaacttttgataatttgctc Reverse, SmaI site, (underlined) and stop codon of hylEfm (Figure 1.)
I tcccccgggttagcgattgatcgagc Reverse, SmaI site (underlined), stop codon of down (Figure 1.)
Jc g ggatcccaatcaagaagtagcggatt Forward, BamH site (underlined) 438 nucleotides upstream of the stop codon of carbohydrate
ABC transporter gene (Figure 1.)
K gcggccgctcgagggcccttagtgcgattgtatctgac Reverse, stop codon of the gene that encodes to transmembrane protein (Figure 1.)
L gggcccctcgaggcggccgcaaaattaaataaaaaatgg Forward, ApaI, XhoI, NotI site, stop codon down (Figure 1.)
Mc atgcatgaatcaggaactgaaactgc Reverse, NsiI site, 1,091 nucleotides upstream of stop codon of GMP synthase (opposite
orientation) (Figure 1.)
N ccggaattccagtaaaaggcacagagc Forward, EcoRI site (underlined), located 2,138 nucleotides down-stream of glycosyl hidrolase
family 45-2 start codon (Figure 1.)
O tcatctattttctcctttgaaagtaatcactatattcc Reverse, stop codon of glycosyl hydrolase family 45-2 (Figure 1.)
P tcaaaggagaaaatagatgaatatcttaaaaaataaaaagc Forward, located 40 nucleotides upstream of down gene start codon (Figure 1.)
Q ataagaatgcggccgcttagcgattgatcgagcg Reverse, NotI site (underlined), stop codon of down (Figure 1.)
R ataagaatgcggccgccagtaaaaggcacagagc Forward, NotI site (underlined), located 2,138 nucleotides down-stream of glycosyl hydrolase
family 45-2 start codon (Figure 1.)
S tcatctattttctcctttgaaagtaatcactatattcc Reverse, stop codon of glycosyl hydrolase family 45-2 (Figure 1.)
T tcaaaggagaaaatagatgacaaaattaaataaaaaatgg Forward, 1,973 nucleotides upstream of stop codon of GMP synthase (Figure 1.)
Uc g gaattcgaatttgtatatgtcttcg Reverse, EcoRI site (underlined), 994 nucleotides upstream of start codon of GMP synthase
(opposite direction) (Figure 1.)
V aaggaaaaaagcggccgccagaatatgataatcgtcatgg Forward, NotI site (underlined), 902 nucleotides downstream of hylEfm start codon (Figure 1.)
W tttgttctcctttttcttgctttttattttttaag Reverse, stop codon of of hylEfm (Figure 1.)
X gcaagaaaaaggagaacaaacaaaattaaataaaaaatgg Forward, 1,973 nucleotides upstream of stop codon of GMP synthase (opposite direction)
(Figure 1.)
Y ccggaattcgaatcaggaactgaaactgccc Reverse, EcoRI site (underlined), 1,094 nucleotides upstream of stop codon of GMP synthase
(opposite direction) (Figure 1.)
A1 cgcgtcgtattaaaaatcat Forward, 143 nucleotides upstream of stop codon of GH20 (Figure 3.)
A2 gatcgataaactggctcgt Reverse, 139 nucleotides upstream of start codon of GH42 (Figure 3.)
B1 acgcgtcgacagcagctggatatgctga Forward, SalI site (underlined), 2,316 nucleotides downstream of start codon of GH42 (Figure 3.)
B2 ggaagatctccggtttccagacttctt Reverse, BglII site (underlined), 159 nucleotides downstream of start codon of hylEfm (Figure 3.)
C1 gttagaagaagtctggaaaccg Forward, 138 nucleotides downstream of start codon of hylEfm (Figure 3.)
C2 tgctaagatattcctctactcg Reverse, 798 nucleotides upstream of stop codon of hylEfm (Figure 3.)
D1 acatgcatgcagaattggagccttggtt Forward, SphI site (underlined), 169 nucleotides upstream of stop codon of hylEfm (Figure 3.)
D2 cggaattctgcttccgcataagaaa Reverse, EcoRI site (underlined), 319 nucleotides upstream of stop codon of down gene
(Figure 3.)
E1 gcaaggcttcttagaga Forward, ddl E. faecium [32,33]
E2 catcgtgtaagctaacttc Reverse, ddl E. faecium [32,33]
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Page 4 of 12with p-Cl-Phe were excisants, the corresponding colo-
nies were grown simultaneously on BHI agar in the pre-
sence and absence of gentamicin. Colonies that were
susceptible to gentamicin were further screened by PCR,
pulsed field gel electrophoresis (PFGE) and hybridiza-
tions with hylEfm and cat probes as described before
[11]. The mutated region was also sequenced in order
to confirm deletion of the corresponding genes. Subse-
quently, the mutated hylEfm-containing plasmid (pHy-
lEfmTX16Δ7,534) was transferred from E. faecium TX16 to
TX1330RF (a fusidic and rifampin resistant derivative of
the commensal strain TX1330, Table 1) by filter mating
as described previously [11] to obtain the strain
TX1330RF(pHylEfmTX16Δ7,534). Acquisition of the
mutated plasmid by TX1330RF was also confirmed by
PFGE, PCR, hybridizations and sequencing. S1 nuclease
digestion and PFGE was performed with the mutant to
confirm that no other plasmid had transferred during
the conjugation event as previously described [11].
Complementation of the hylEfm-region mutant TX1330RF
(pHylEfmTX16Δ7,534)
The hylEfm gene was PCR amplified with primers G and
H (including the ribosomal binding site and the stop
codon of hylEfm) (Table 2) using total DNA from TX16
as template, and the DNA fragment (1,685 bp) cloned
into the shuttle plasmid pAT392 [30] under the control
of the P2 promoter (which allows constitutive expression
of the cloned genes) and upstream of the aac(6’)-aph(2”)
gene (which is co-transcribed from the same promoter)
using SacI and SmaI sites (plasmid pAT392::hylEfm). In
order to evaluate if the deletion of hylEfm had an effect in
the downstream gene (encoding a hypothetical protein of
331 amino acids of unknown function), the hylEfm and
down genes (Figure 1) were also cloned together into
pAT392 following a similar strategy and using primers G
and I (pAT392::hylEfm-down). Recombinant pAT392-
derivatives were purified from E. coli g r o w no nL u r i a -
Bertani agar containing gentamicin (25 μg/ml) and all
their DNA inserts sequenced. Subsequently, they were
introduced into E. faecium TX1330RF, and the
TX1330RF(pHylEfmTX16Δ7,534) mutant by electroporation.
Stability of the plasmid constructs was tested by isolating
ca. 100 colonies from overnight cultures (using BHI
broth) and from the spleens of dead animals (in different
experiments) after intraperitoneal inoculation of the cor-
responding strain (see below) and plating them simulta-
neously on BHI and BHI-gentamicin (125 μg/ml).
Construction of additional mutants of the hylEfm-region in
E. faecium TX1330RF(pHylEfmTX16)
T oi n v e s t i g a t et h es p e c i f i cr o l eo ft h ehylEfm locus in E.
faecium pathogenesis, complete in-frame deletions of
four genes of the hylEfm-region, hylEfm alone, hylEfm plus
its downstream gene and the gene downstream of hylEfm
were generated using TX1330RF(pHylEfmTX16). Frag-
ments upstream and downstream of each region were
amplified by PCR with the corresponding primers
Figure 2 Physical map of the plasmids pHOU1 and pHOU2 for targeted mutagenesis of E. faecium. A, plasmid used for construction of
TX1330RF (pHylEfmTX16Δ4genes), TX1330RF(pHylEfmTX16Δhyl), TX1330RF(pHylEfmTX16Δhyl-down) and TX1330RF (pHylEfmTX16Δdown) deletion mutants (Figure 1);
B, plasmid used for construction of the TX1330RF(pHylEfmTX16Δ7,534)d e l e t i o nm u t a n t( F i g u r e1 ) .
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ends, were subsequently amplified by crossover PCR and
cloned into pHOU1 using EcoRI and NotI (for hylEfm,
hylEfm plus its downstream gene and the downstream gene
of hylEfm mutants); and BamHI and PstI (for the four gene
mutant). The inserts were sequenced in both directions to
confirm that no mutations had been introduced during
the cloning process. The recombinant plasmids were elec-
troporated or transferred by conjugation (using E. faecalis
CK111) into TX1330RF(pHylEfmTX16). Single crossover
events and deletions of targeted regions (Figure 1) were
obtained by plating in BHI with gentamicin and p-Cl-Phe
containing medium, respectively, as previously described
[25]. Confirmation of the deletion was performed by PCR,
PFGE, hybridizations and DNA sequencing.
RT-PCR
RNA was extracted from bacterial cells (TX16,
TX1330RF(pHylEfmTX16), TX1330RF and strains contain-
ing pAT392 derivatives) grown in BHI broth at 37°C with
mild agitation (logarithmic phase of growth, A600 0.8) as
described before [31], and using the RNA isolation kit
RNAwiz (Ambion, Austin, TX). RNA was treated twice
with DNase (DNase-Free solution, Ambion) and synth-
esis of cDNA was performed using the commercial kit
SuperScript One-Step reverse transcription-PCR (RT-
PCR) with Platinum Taq (Invitrogen), according to the
manufacturer’s instructions. The mixture contained 0.2
μM of each primer, designed to detect overlapping tran-
scripts of the four putative metabolic genes (Figure 3)
and an internal transcript of hylEfm (Table 2). A primer
pair directed to detect a 550-bp transcript of the house-
keeping gene ddlE. faecium was used as an internal control
for RT-PCR experiments [32,33].
Mouse peritonitis model
Female (4 to 6 week old), outbred ICR mice (Harlan
Sprague Dawley, Houston) were used as previously
d e s c r i b e d[ 3 4 ] .G r o u p so f1 0m i c ep e ri n o c u l u m( r a n -
ging from 2.3 × 10
8 to 3.1 × 10
9 CFU/ml) were included
in each experiment. Inocula for each peritonitis experi-
ment were prepared by growing bacteria initially on BHI
agar plates. Subsequently, one colony was grown in BHI
broth for 24 h at 37°C and the cells were concentrated
in saline (0.9%) to an A600 of ca. 1.2. Strains containing
pAT392 and derivatives were handled similarly before
the intraperitoneal inoculation, except that the BHI agar
and broth contained gentamicin (125 μg/ml). Compari-
son of the survival curves at similar inocula was per-
formed using a log-rank test with Prism for Windows
®.
A P < 0.05 was considered significant. All experiments
were approved by the Animal Welfare committee, Uni-
versity of Texas Health Science Center at Houston.
Results and Discussion
Deletion of 6 genes in the E. faecium hylEfm-region altered
in vitro growth and attenuated virulence of TX1330RF
(pHylEfmTX16) but not TX16(pHylEfmTX16) in murine
peritonitis
Since acquisition of the transferable pHylEfmTX16 by
TX1330RF conferred increased virulence in experimen-
tal peritonitis [11], we explored the possibility that the
hylEfm region was an important mediator of this effect.
Using RT-PCR assays, we were able to detect in vitro
expression of hylEfm during the exponential phase of
growth in both TX16 and TX1330RF (pHylEfmTX16)
(Figure 3). RT-PCR with primers located at the 3’ and 5’
ends of contiguous genes yielded products of the
expected size in each case, suggesting that these genes
are likely to be co-transcribed (Figure 3). Then, we
adapted the pheS* counter-selection system [25] devel-
oped for E. faecalis to obtain several deletions of the
hylEfm-region. The hylEfm gene in E. faecium TX16
(http://www.ncbi.nlm.nih.gov/genomeprj/30627, Gen-
bank accession number ACIY00000000) is located in a
cluster of genes whose putative function appears to
involve the transport and breakdown of carbohydrates
(Figure 1) [13]. As an initial step to test the mutagenesis
system, a relatively large deletion (7,534 bp) from pHy-
lEfmTX16 was obtained. The deletion involved three genes
predicted to encode glycosyl hydrolases (including
hylEfm) and a gene downstream of hylEfm whose function
is unknown (Figure 1). Part (226 nucleotides) of a gene
encoding a hypothetical transmembrane protein and
located upstream of the putative family 20 glycosyl
hydrolase gene and part (202 nucleotides) of a gene
located 1,332 nt downstream of hylEfm encoding a puta-
tive GMP-synthase and likely transcribed in the opposite
direction from the hylEfm cluster (Figure 1) were also
deleted. As it is shown in Figure 4A, the deletion of
7,534 bp in the hylEfm-region did not affect the virulence
of TX16 (DO) in murine peritonitis.
Next, we considered the possibility that an in vivo
effect might be more clearly dissected if studies were
performed in the background of a non-clinical strain.
We hypothesized that an in vivo effect of a virulence
determinant might more likely be seen in strains which
are less successful clinically; that is, that a commensal
strain such as TX1330RF [11] is likely to have decreased
fitness or ability to produce disease compared to TX16
[35] and, thus, acquisition plus subsequent loss of a
virulence determinant that alters such fitness would be
easier to identify [11]. Thus, the mutated plasmid from
strain TX16(pHylEfmTX16Δ7,534) was transferred to
TX1330RF by conjugation and the in vivo effect of
acquiring the intact plasmid [11] vs the plasmid carrying
the deletion was evaluated. The two strains [TX1330RF
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appeared to differ only in the size of the hylEfm plasmid
by PFGE and S1 nuclease assays [11] (not shown).
Figure 4B shows that deletion of 7,534 bp in the hylEfm
region of TX1330RF(pHylEfmTX16)c a u s e da nin vitro
growth defect. The alteration of growth was also seen in
a second transconjugant from the same mating experi-
ment between TX16(pHylEfmTX16Δ7,534) and TX1330RF
(TC-II in Figure 4B). The mutant strain TX1330RF
(pHylEfmTX16Δ7,534) was attenuated in the mouse model
of peritonitis (even when an increased intraperitoneal
inoculum for the mutant were used) (Figure 4C and 4D)
(P < 0.05). Due to the alterations produced in the
growth of TX1330RF(pHylEfmTX16Δ7,534), these results
suggest that the attenuation in virulence may have also
been due to factors other than those specifically related
to virulence.
Complementation of the hylEfm-region mutant with hylEfm
and a combination of hylEfm and the downstream gene
did not restore the virulence of TX1330RF
(pHylEfmTX16Δ7,534)
In order to further evaluate if the attenuation observed
in TX1330RF(pHylEfmTX16Δ7,534) (as described above)
Figure 3 Transcriptional analysis of genes in the hylEfm region using reverse transcriptase (RT)-PCR. A, physical map of the hylEfm region
and primers used for RT-PCR experiments. Black arrows above the genes indicate the position of the primers used to amplify DNA sequences
from the cDNA obtained after reverse transcription. B, RT-PCR using primers A1-A2; C, RT-PCR using primes B1-B2; D, RT-PCR using primers C1-
C2; E, RT-PCR using primers D1-D2; F, RT-PCR with ddl as the target gene using primers E1-E2 (Table 2) [32,33]. Lanes 1 and 2, TX1330RF (RT-PCR
reaction and control without RT enzyme, respectively); lanes 3 and 4, TX1330RF(pHylEfm16) (RT-PCR reaction and control without RT enzyme,
respectively); lanes 5 and 6 TX16(pHylEfm16) (RT-PCR reaction and control without RT enzyme respectively). The molecular weight of the bands is
indicated to the right.
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Page 7 of 12was mediated by a direct effect of hylEfm in the peritoni-
tis model, we explored complementation of this mutant
in trans with the full hylEfm gene and a combination of
hylEfm and the downstream gene using the shuttle vector
pAT392 [30]. The cloning strategy placed these genes
upstream of the aac(6’)-aph(2”) gene (which confers
resistance to gentamicin) resulting in all open reading
frames under the control of the constitutive P2 promo-
ter. Up to 80% loss was observed with all strains in the
absence of gentamicin; however, in the presence of the
antibiotic during inoculum preparation, the TX1330RF
(pHylEfmTX16Δ7,534)-derivatives containing the pAT392
constructs were stable both in vitro and in vivo (5%
maximum percentage of plasmid loss). Introduction of
hylEfm or a combination of hylEfm plus its downstream
gene (cloned into pAT392) did not restore the virulence
of the mutant strain TX1330RF(pHylEfmTX16Δ7,534), com-
pared to pAT392 alone in the presence of gentamicin
(Figure 5A and 5B). The results indicate that constitu-
tive expression of hylEfm alone or in combination with
its downstream gene (which was confirmed by RT-PCR,
n o ts h o w n )w a sn o ta b l et or e s t o r et h ep h e n o t y p i cd i f -
ferences observed in the mutant strain TX1330RF(pHy-
lEfmTX16Δ7,534), supporting the fact that hylEfm may not
be directly responsible of the attenuation observed in
the mutant.
Under our experimental conditions, we cannot com-
pletely rule out that the in vivo attenuation observed
with pHylEfmTX16Δ7,534 in the TX1330RF background
m a yh a v eb e e nc a u s e db yt h ep a r t i a ld e l e t i o no ft h e
hypothetical transmembrane protein or the putative
GMP-synthase located upstream and downstream of the
hylEfm-cluster, respectively. Indeed, a deletion of 76
amino acids in the C-terminus of the hypothetical mem-
brane protein occurred in this plasmid, resulting in the
deletion of three predicted transmembrane helices.
Figure 4 Growth and survival curves in the mouse peritonitis model of E. faecium TX0016(pHylEfmTX16) and TX1330RF(pHylEfmTX16),
carrying an intact hylEfm-region, and pHylEfmTX16Δ7,534 (6 gene mutant of the hylEfm-region). A, Survival curve of representative inoculum (5
inocula per experiment in two independent experiments) of TX0016(pHylEfmTX16) vs TX0016(pHylEfmTX16Δ7,534) in mouse peritonitis; B, growth
curves of TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ7,534) and a second transconjugant [TX1330RF(pHylEfmTX16Δ7,534)-TCII] obtained from the
same mating experiment between TX16(pHylEfmTX16Δ7,534) and TX1330RF, expressed as optical density (A600) in brain heart infusion (BHI) broth
(results of at least three experiments per strain). C and D, survival curves of TX1330RF(pHylEfmTX16) vs TX1330RF(pHylEfmTX16Δ7,534) obtained in the
peritonitis model at different inocula in independent experiments performed at different days.
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tive GMP-synthase were deleted; the removal of these
amino acids is likely to disturb the dimerization domain
of this protein [36] affecting its function in nucleotide
metabolism. Moreover, a second TX1330RF(pHy-
lEfmTX16Δ7,534) mutant also exhibited an almost identical
growth defect (Figure 4B). Thus, it is tempting to specu-
late that changes in these two genes may have affected
the “metabolic” fitness of the TX1330RF(pHy-
lEfmTX16Δ7,534) strain. However, since no evident change
in fitness or virulence was observed with the mutated
plasmid in the TX16 background, another possibility is
that an extraneous change elsewhere in the plasmid (or
chromosome) occurred during the conjugation process
that influenced the in vitro growth of the TX1330RF
(pHylEfmTX16Δ7,534) mutant(s) and its virulence.
Additional deletions of genes in the hylEfm-region did not
alter the virulence of TX1330RF(pHylEfmTX16) in the mouse
peritonitis model
In order to dissect further the in vivo role of hylEfm and
the adjacent genes, we produced several in-frame dele-
tions of these genes (Figure 1) including: i)af o u rg e n e
mutant of the hylEfm-region (including hylEfm)
[TX1330RF(pHylEfmTX16Δ4genes)], ii) a deletion of hylEfm
alone [TX1330RF (pHylEfmTX16Δhyl)], iii) a deletion of
hylEfm plus its downstream gene mutant [TX1330RF
(pHylEfmTX16Δhyl-down)] and, iv) a single deletion of the
gene located downstream from hylEfm [TX1330RF
(pHylEfmTX16Δdown)]. The mutagenesis strategy removed
the open reading frame from the start codon of the first
gene to the stop codon of the last gene (in case of mul-
tiple genes). In case of single gene deletion, the com-
plete ORF (start to stop codon) was removed, leaving
the surrounding DNA intact as in the wild type plasmid.
None of the four mutants of the hylEfm-region showed a
deleterious effect in the growth kinetics compared to
TX1330RF (pHylEfmTX16) (harbouring an intact plasmid,
Additional file 1). Moreover, we were unable to observe
any attenuation of virulence in the mouse peritonitis
model compared to the parental strain with the intact
plasmid (Figure 6A-D), which further supports the
fact that the four genes of the hylEfm region do not
appear to be directly involved in increasing the patho-
genic potential of pHylEfmTX16 in strain TX1330RF
(pHylEfmTX16).
Megaplasmids (>145 kb, with or without hylEfm)h a v e
been recently found to be widespread among clinical iso-
lates of E. faecium worldwide [12,13,15]. The proportion
of these plasmids carrying hylEfm appears to vary accord-
ing to geographical location (ca. 11 to 36%) [12,13]. Our
findings indicate that the four genes of the hylEfm-cluster
studied here, including hylEfm are not the main mediators
of the virulence effect conferred by the plasmid carrying
them in experimental peritonitis. Since the pHylEfm plas-
mids are large, it is presumed that other genes (i.e.,
upstream or downstream of the glycoside hydrolase-
encoding genes) are more relevant in mediating this
Figure 5 Survival curves in the mouse peritonitis model of E. faecium TX1330RF and derivatives. A and B show survival curves of the
TX1330RF(pHylEfmTX16Δ7,534) (6 gene mutant in the hylEfm region) complemented with pAT392-derivatives (which include pAT392::hylEfm and
pAT392::hylEfm-down) obtained in the peritonitis model at different inocula in independent experiments performed at different days. The asterisk
indicates that the lines are superimposed since values are identical.
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Page 9 of 12effect. Additionally, we cannot exclude that the hylEfm
cluster studied in this work may play a role in other
infections such as endocarditis or urinary tract infections
(a subject of our ongoing studies). As a final remark, the
adaptation of the pheS* counter-selection system for
targeted mutagenesis in plasmid and chromosomal genes
of E. faecium will facilitate the understanding of the role
of other specific plasmid genes in the pathogenesis of
E. faecium infections in the near future.
Conclusions
We provided evidence that four genes of the hylEfm-
region (including hylEfm) do not mediate the virulence
effect of the E. faecium plasmid pHylEfm in experimental
peritonitis. The adaptation of the PheS* counter-selec-
tion system for targeted mutagenesis of E. faecium
should facilitate the study of the role of other pHylEfm
genes in the pathogenesis of murine peritonitis.
Additional material
Additional file 1: Growth curves of E. faecium and mutants. The
strains were incubated in BHI broth and the A600 were measured every
hour.
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